Terms: = Sarcomas AND KIT, C-Kit, 3815, ENSG00000157404, CD117, SCFR, P10721 AND Staging
12 results:
1. LncRNA MATN1-AS1 for Prediction of Prognosis in Osteosarcoma Patients and Its Cellular Function.
Liu Y; Wang D; Ji Q; Yan J
Mol Biotechnol; 2022 Jan; 64(1):66-74. PubMed ID: 34542816
[TBL] [Abstract] [Full Text] [Related]
2. [Clinicopathological features of myeloid sarcoma and DLBCL in the breast: a comparative study].
Chen DB; Zhang H; Kong FZ; Jiang Q; Fang XZ; Shen DH; Kan X
Zhonghua Bing Li Xue Za Zhi; 2020 Mar; 49(3):250-255. PubMed ID: 32187897
[No Abstract] [Full Text] [Related]
3. Clinicopathologic Correlation of Kaposi Sarcoma Involving the Ocular Adnexa: Immunophenotyping of Diagnostic and Therapeutic Targets.
Ulloa-Padilla JP; Ghassibi MP; Dubovy SR; Kerr DA
Ophthalmic Plast Reconstr Surg; 2020; 36(2):185-190. PubMed ID: 31743287
[TBL] [Abstract] [Full Text] [Related]
4. Intracranial Interdigitating Dendritic Cell Sarcoma: First Case Report.
Hutter G; Hofer S; Tzankov A; Kothbauer KF
Neurosurgery; 2015 Dec; 77(6):E979-83. PubMed ID: 26237342
[TBL] [Abstract] [Full Text] [Related]
5. Primary malignant melanoma of the breast: case report and review of the literature.
Drueppel D; Schultheis B; Solass W; Ergonenc H; Tempfer CB
Anticancer Res; 2015 Mar; 35(3):1709-13. PubMed ID: 25750332
[TBL] [Abstract] [Full Text] [Related]
6. Recurrence risk after resection of gastrointestinal stromal tumors: size is not all that matters... The consequences of tumor rupture.
Han D; Deneve J; Gonzalez RJ
Am Surg; 2012 Jan; 78(1):74-9. PubMed ID: 22273319
[TBL] [Abstract] [Full Text] [Related]
7. Clinical utility of the new American Joint Committee on Cancer staging system for gastrointestinal stromal tumors: current overall survival after primary tumor resection.
Rutkowski P; Wozniak A; Dębiec-Rychter M; Kąkol M; Dziewirski W; Zdzienicki M; Ptaszynski K; Jurkowska M; Limon J; Siedlecki JA
Cancer; 2011 Nov; 117(21):4916-24. PubMed ID: 21456019
[TBL] [Abstract] [Full Text] [Related]
8. Integrative genomic characterization and a genomic staging system for gastrointestinal stromal tumors.
Ylipää A; Hunt KK; Yang J; Lazar AJ; Torres KE; Lev DC; Nykter M; Pollock RE; Trent J; Zhang W
Cancer; 2011 Jan; 117(2):380-9. PubMed ID: 20818650
[TBL] [Abstract] [Full Text] [Related]
9. Perspective on updated treatment guidelines for patients with gastrointestinal stromal tumors.
Blay JY; von Mehren M; Blackstein ME
Cancer; 2010 Nov; 116(22):5126-37. PubMed ID: 20661913
[TBL] [Abstract] [Full Text] [Related]
10. Molecular classification of soft tissue sarcomas and its clinical applications.
Jain S; Xu R; Prieto VG; Lee P
Int J Clin Exp Pathol; 2010 Apr; 3(4):416-28. PubMed ID: 20490332
[TBL] [Abstract] [Full Text] [Related]
11. Pleuro-pulmonary solitary fibrous tumors: a clinicopathologic, immunohistochemical, and molecular study of 88 cases confirming the prognostic value of de Perrot staging system and p53 expression, and evaluating the role of c-kit, BRAF, PDGFRs (alpha/beta), c-met, and EGFR.
Schirosi L; Lantuejoul S; Cavazza A; Murer B; Yves Brichon P; Migaldi M; Sartori G; Sgambato A; Rossi G
Am J Surg Pathol; 2008 Nov; 32(11):1627-42. PubMed ID: 18753943
[TBL] [Abstract] [Full Text] [Related]
12. Imatinib mesylate for the treatment of gastrointestinal stromal tumours: best monitored with FDG PET.
Jager PL; Gietema JA; van der Graaf WT
Nucl Med Commun; 2004 May; 25(5):433-8. PubMed ID: 15100500
[TBL] [Abstract] [Full Text] [Related]
